JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
February 07, 2017 11:38 ET
|
JDRF/FRDJ
VANCOUVER, BC--(Marketwired - February 07, 2017) - JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow...
Antidiabetics Market – Global Industry Analysis Report, Size, Share, Growth, Price Trends and Forecast, 2023: Fractovia.org
December 14, 2016 06:06 ET
|
Global Market Insights
Ocean View, Delaware, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Antidiabetics market is anticipated to surpass USD 116 billion revenue by 2023 owing to the alarming diabetes occurrence rate worldwide....
XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital Hyperinsulinism
October 19, 2016 09:00 ET
|
XOMA Ltd.
BERKELEY, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today the United Kingdom’s...
XOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical Studies
September 15, 2016 19:26 ET
|
XOMA Ltd.
Results Demonstrate XOMA 358 Mechanism-of-Action in Rare Endocrine ConditionsCompany Plans to Advance XOMA 358 to Multi-dose Phase 2b Studies BERKELEY, Calif., Sept. 15, 2016 (GLOBE...
Antidiabetics Market size worth USD 116 Billion by 2023: Global Market Insights Inc.
July 05, 2016 11:00 ET
|
Global Market Insights
Ocean View, Delaware, July 05, 2016 (GLOBE NEWSWIRE) -- Global Antidiabetics Market size is estimated to reach USD 116.1 billion by 2023; as per the latest research report by Global Market...
Global Insulin Market to Rise with Increasing Awareness about Diabetes Management as Key Growth Driver: QYResearchReports.com
June 13, 2016 08:11 ET
|
QY Research Reports
Brooklyn, NY , June 13, 2016 (GLOBE NEWSWIRE) -- QYResearchReports.com announces the addition of a new research report titled “Global Insulin Market Professional Survey Report 2016.”This study...
XOMA Initiates XOMA 358 Proof-of-Concept Study in Patients with Hypoglycemia Post Gastric Bypass Surgery
April 27, 2016 09:00 ET
|
XOMA Corporation
BERKELEY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has initiated its...
Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment
February 08, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - February 08, 2016) - Johnson & Johnson (J&J), like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1...
Helmsley Charitable Trust Awards $3.4 Million to DreaMed Diabetes for Type 1 Diabetes Decision Support
February 03, 2016 16:22 ET
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, N.Y., Feb. 3, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust today announced a $3.4 million grant for DreaMed Diabetes (DreaMed)....
PharmaCyte Biotech Creates Faster Path to the Clinic for Company's Diabetes Treatment
May 20, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 20, 2015) - PharmaCyte Biotech (OTCQB: PMCB) has managed to do something that is rarely done in science -- bring together an international group of leading experts to...